United Therapeutics (UTHR) Tops Q3 EPS by 73c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
Go back to United Therapeutics (UTHR) Tops Q3 EPS by 73c, Revenues Beat
November 1, 2018 9:16 AM EDT
United Therapeutics Corporation (NASDAQ: UTHR) announced today the appointment of Nilda Mesa to its Board of Directors as an independent director. The appointment is effective as of October 31, 2018.
Mesa has had a long and innovative career in environment, energy and sustainability at the city, state, national and global levels, and now writes and presents extensively on climate, energy, equity and urban systems relating to them. From 2012-2014, Mesa served as Director of the New York City Mayor's Office of Sustainability, where she led the pathbreaking OneNYC long term sustainability plan for the... More
October 31, 2018 12:28 PM EDT
Cowen analyst Chris Shibutani lowered the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $106.00 (from $110.00) while maintaining a Market Perform rating.
...
More
